Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 6.10M | 5.93M | 5.51M | 3.24M | 2.28M | 793.09K |
Gross Profit | 3.42M | 3.72M | 3.62M | 2.12M | -676.98K | -435.65K |
EBITDA | -5.35M | -4.20M | -4.33M | -3.31M | -3.25M | -924.55K |
Net Income | -6.01M | -4.81M | -4.73M | -3.55M | -3.44M | -1.07M |
Balance Sheet | ||||||
Total Assets | 8.06M | 7.79M | 9.25M | 8.46M | 4.76M | 1.98M |
Cash, Cash Equivalents and Short-Term Investments | 777.12K | 158.22K | 164.30K | 3.02M | 905.05K | 128.57K |
Total Debt | 3.76M | 3.85M | 7.16M | 3.85M | 3.39M | 2.59M |
Total Liabilities | 7.65M | 5.19M | 8.41M | 4.17M | 3.57M | 2.73M |
Stockholders Equity | 415.58K | 2.60M | 846.41K | 4.29M | 1.20M | -752.40K |
Cash Flow | ||||||
Free Cash Flow | -1.18M | -4.56M | -5.59M | -3.98M | -2.45M | -1.00M |
Operating Cash Flow | -1.05M | -3.45M | -3.18M | -3.30M | -1.95M | -884.93K |
Investing Cash Flow | 11.76K | -977.22K | -2.41M | -681.53K | -498.22K | -115.84K |
Financing Cash Flow | 1.75M | 4.42M | 2.74M | 6.09M | 3.22M | 1.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
60 Neutral | $8.20M | 1.25 | 26.62% | ― | 16.65% | ― | |
57 Neutral | HK$24.54B | 3.87 | -2.03% | 6.53% | -0.31% | -67.70% | |
51 Neutral | $91.53M | ― | 229.13% | ― | 7.02% | 74.19% | |
47 Neutral | $7.70M | ― | -28.39% | ― | 4.71% | -72.09% | |
46 Neutral | $458.08M | ― | -67.84% | ― | -9.23% | -3.69% | |
44 Neutral | $403.99K | ― | ― | ― | ― | ||
43 Neutral | $15.22M | ― | -402.19% | ― | 3.39% | 39.45% |
On May 29, 2025, Reborn Coffee, Inc. received a notification from Nasdaq indicating that its stockholders’ equity had fallen below the required minimum of $2,500,000 for continued listing. As of March 31, 2025, the company’s stockholders’ equity was reported at $415,582. The notification does not immediately affect the company’s listing, but Reborn Coffee has until July 13, 2025, to submit a compliance plan. If accepted, Nasdaq may grant an extension until November 25, 2025, to meet the requirements. The company is exploring options to regain compliance, but there is no assurance of success.